Rahul Rangwa 새 기사를 만들었습니다
4 디 - 번역하다

North America Adalimumab Market Experiences Strong Uptake Driven by Rising Prevalence of Autoimmune Disorders | #north America Adalimumab Market

North America Adalimumab Market Experiences Strong Uptake Driven by Rising Prevalence of Autoimmune Disorders

North America Adalimumab Market Experiences Strong Uptake Driven by Rising Prevalence of Autoimmune Disorders

Data Bridge Market Research analyses a growth rate in the adalimumab market in the forecast period 2023-2030. The expected CAGR of adalimumab market is tend to be around 5.40 % in the mentioned forecast period.